ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/01/05 | 2,065 | 2,068 | 2,029 | 2,033 | -12 | -0.6% | 52,200 |
2024/01/04 | 2,017 | 2,054 | 1,995 | 2,045 | +28 | +1.4% | 75,400 |
2023/12/29 | 2,020 | 2,027 | 2,005 | 2,017 | -1 | ±0% | 41,800 |
2023/12/28 | 2,009 | 2,018 | 1,999 | 2,018 | +8 | +0.4% | 52,000 |
2023/12/27 | 2,000 | 2,012 | 1,998 | 2,010 | +8 | +0.4% | 95,900 |
2023/12/26 | 2,000 | 2,012 | 1,997 | 2,002 | +7 | +0.4% | 71,000 |
2023/12/25 | 2,000 | 2,007 | 1,993 | 1,995 | +14 | +0.7% | 88,400 |
2023/12/22 | 1,970 | 1,983 | 1,970 | 1,981 | +19 | +1% | 53,200 |
2023/12/21 | 1,960 | 1,970 | 1,959 | 1,962 | -13 | -0.7% | 34,200 |
2023/12/20 | 1,960 | 1,979 | 1,959 | 1,975 | +22 | +1.1% | 54,000 |
2023/12/19 | 1,944 | 1,953 | 1,931 | 1,953 | +9 | +0.5% | 67,600 |
2023/12/18 | 1,938 | 1,948 | 1,922 | 1,944 | -4 | -0.2% | 45,000 |
2023/12/15 | 1,975 | 1,975 | 1,946 | 1,948 | -28 | -1.4% | 105,200 |
2023/12/14 | 1,981 | 1,993 | 1,968 | 1,976 | -8 | -0.4% | 37,800 |
2023/12/13 | 1,996 | 1,996 | 1,977 | 1,984 | -14 | -0.7% | 57,900 |
2023/12/12 | 2,019 | 2,024 | 1,995 | 1,998 | -22 | -1.1% | 49,700 |
2023/12/11 | 2,001 | 2,020 | 2,001 | 2,020 | +19 | +0.9% | 53,100 |
2023/12/08 | 2,022 | 2,022 | 1,991 | 2,001 | -11 | -0.5% | 99,900 |
2023/12/07 | 2,045 | 2,053 | 2,012 | 2,012 | -33 | -1.6% | 70,100 |
2023/12/06 | 2,024 | 2,049 | 2,020 | 2,045 | +23 | +1.1% | 65,900 |
2023/12/05 | 2,038 | 2,047 | 2,019 | 2,022 | -11 | -0.5% | 67,600 |
2023/12/04 | 2,040 | 2,043 | 2,015 | 2,033 | -11 | -0.5% | 73,500 |
2023/12/01 | 2,036 | 2,057 | 2,034 | 2,044 | +18 | +0.9% | 95,900 |
2023/11/30 | 2,017 | 2,032 | 2,001 | 2,026 | +12 | +0.6% | 100,700 |
2023/11/29 | 2,009 | 2,018 | 1,995 | 2,014 | +21 | +1.1% | 98,600 |
2023/11/28 | 1,970 | 1,994 | 1,958 | 1,993 | +23 | +1.2% | 74,800 |
2023/11/27 | 1,995 | 1,995 | 1,966 | 1,970 | -5 | -0.3% | 58,000 |
2023/11/24 | 1,973 | 1,975 | 1,955 | 1,975 | +22 | +1.1% | 70,700 |
2023/11/22 | 1,942 | 1,965 | 1,942 | 1,953 | +11 | +0.6% | 79,000 |
2023/11/21 | 1,923 | 1,944 | 1,918 | 1,942 | +21 | +1.1% | 69,500 |
2023/11/20 | 1,944 | 1,953 | 1,918 | 1,921 | -15 | -0.8% | 93,800 |
2023/11/17 | 1,917 | 1,936 | 1,907 | 1,936 | +32 | +1.7% | 80,700 |
2023/11/16 | 1,902 | 1,924 | 1,896 | 1,904 | +2 | +0.1% | 98,900 |
2023/11/15 | 1,907 | 1,913 | 1,886 | 1,902 | +7 | +0.4% | 86,900 |
2023/11/14 | 1,889 | 1,907 | 1,881 | 1,895 | +6 | +0.3% | 78,200 |
2023/11/13 | 1,920 | 1,920 | 1,880 | 1,889 | -18 | -0.9% | 101,400 |
2023/11/10 | 1,891 | 1,907 | 1,881 | 1,907 | +4 | +0.2% | 102,400 |
2023/11/09 | 1,916 | 1,919 | 1,885 | 1,903 | -7 | -0.4% | 128,700 |
2023/11/08 | 1,934 | 1,936 | 1,894 | 1,910 | -12 | -0.6% | 188,300 |
2023/11/07 | 1,945 | 1,957 | 1,920 | 1,922 | -25 | -1.3% | 130,200 |
2023/11/06 | 1,999 | 2,000 | 1,945 | 1,947 | -21 | -1.1% | 169,600 |
2023/11/02 | 1,946 | 1,983 | 1,912 | 1,968 | -80 | -3.9% | 264,400 |
2023/11/01 | 2,011 | 2,050 | 2,008 | 2,048 | +52 | +2.6% | 170,900 |
2023/10/31 | 1,970 | 1,998 | 1,967 | 1,996 | +34 | +1.7% | 118,500 |
2023/10/30 | 1,991 | 1,991 | 1,951 | 1,962 | -49 | -2.4% | 122,700 |
2023/10/27 | 1,987 | 2,011 | 1,970 | 2,011 | +48 | +2.4% | 70,800 |
2023/10/26 | 1,990 | 2,002 | 1,963 | 1,963 | -16 | -0.8% | 108,100 |
2023/10/25 | 1,999 | 1,999 | 1,977 | 1,979 | -8 | -0.4% | 108,200 |
2023/10/24 | 2,000 | 2,008 | 1,954 | 1,987 | -8 | -0.4% | 102,800 |
2023/10/23 | 1,989 | 2,017 | 1,988 | 1,995 | -13 | -0.6% | 145,400 |
401~
450
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 206,000円 | +3.1% | -6.5% | 2.33% | 9.56倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 274,000円 | +21.7% | +999.9% | 0.00% | 12.62倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 318,500円 | +5.1% | -7.0% | 2.51% | 20.91倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 154,600円 | -2.4% | -52.3% | 3.69% | 18.50倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 238,900円 | +4.1% | -3.1% | 2.43% | 20.75倍 | 1.81倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム